Melatonin uptake through glucose transporters

A new target for melatonin inhibition of cancer

David Hevia, Pedro González-Menéndez, Isabel Quiros-González, Ana Miar, Aida Rodríguez-García, Dun Xian Tan, Russel J Reiter, Juan C. Mayo, Rosa M. Sainz

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Melatonin is present in a multitude of taxa and it has a broad range of biological functions, from synchronizing circadian rhythms to detoxifying free radicals. Some functions of melatonin are mediated by its membrane receptors but others are receptor-independent. For the latter, melatonin must enter into the cell. Melatonin is a derivative of the amino acid tryptophan and reportedly easily crosses biological membranes due to its amphipathic nature. However, the mechanism by which melatonin enters into cells remains unknown. Changes in redox state, endocytosis pathways, multidrug resistance, glycoproteins or a variety of strategies have no effect on melatonin uptake. Herein, it is demonstrated that members of the SLC2/GLUT family glucose transporters have a central role in melatonin uptake. When studied by docking simulation, it is found that melatonin interacts at the same location in GLUT1 where glucose does. Furthermore, glucose concentration and the presence of competitive ligands of GLUT1 affect the concentration of melatonin into cells. As a regulatory mechanism, melatonin reduces the uptake of glucose and modifies the expression of GLUT1 transporter in prostate cancer cells. More importantly, glucose supplementation promotes prostate cancer progression in TRAMP mice, while melatonin attenuated glucose-induced tumor progression and prolonged the lifespan of tumor-bearing mice. This is the first time that a facilitated transport of melatonin is suggested. In fact, the important role of glucose transporters and glucose metabolism in cell fate might explain some of the diverse functions described for melatonin.

Original languageEnglish (US)
Pages (from-to)234-250
Number of pages17
JournalJournal of Pineal Research
Volume58
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Facilitative Glucose Transport Proteins
Melatonin
Neoplasms
Glucose
Prostatic Neoplasms
Membranes
Multiple Drug Resistance
Circadian Rhythm
Endocytosis
Tryptophan
Oxidation-Reduction
Free Radicals
Glycoproteins

Keywords

  • cancer
  • glucose
  • glucose transporter
  • Melatonin
  • prostate
  • transgenic adenocarcinoma of the mouse prostate
  • transporter

ASJC Scopus subject areas

  • Endocrinology

Cite this

Hevia, D., González-Menéndez, P., Quiros-González, I., Miar, A., Rodríguez-García, A., Tan, D. X., ... Sainz, R. M. (2015). Melatonin uptake through glucose transporters: A new target for melatonin inhibition of cancer. Journal of Pineal Research, 58(2), 234-250. https://doi.org/10.1111/jpi.12210

Melatonin uptake through glucose transporters : A new target for melatonin inhibition of cancer. / Hevia, David; González-Menéndez, Pedro; Quiros-González, Isabel; Miar, Ana; Rodríguez-García, Aida; Tan, Dun Xian; Reiter, Russel J; Mayo, Juan C.; Sainz, Rosa M.

In: Journal of Pineal Research, Vol. 58, No. 2, 2015, p. 234-250.

Research output: Contribution to journalArticle

Hevia, D, González-Menéndez, P, Quiros-González, I, Miar, A, Rodríguez-García, A, Tan, DX, Reiter, RJ, Mayo, JC & Sainz, RM 2015, 'Melatonin uptake through glucose transporters: A new target for melatonin inhibition of cancer', Journal of Pineal Research, vol. 58, no. 2, pp. 234-250. https://doi.org/10.1111/jpi.12210
Hevia D, González-Menéndez P, Quiros-González I, Miar A, Rodríguez-García A, Tan DX et al. Melatonin uptake through glucose transporters: A new target for melatonin inhibition of cancer. Journal of Pineal Research. 2015;58(2):234-250. https://doi.org/10.1111/jpi.12210
Hevia, David ; González-Menéndez, Pedro ; Quiros-González, Isabel ; Miar, Ana ; Rodríguez-García, Aida ; Tan, Dun Xian ; Reiter, Russel J ; Mayo, Juan C. ; Sainz, Rosa M. / Melatonin uptake through glucose transporters : A new target for melatonin inhibition of cancer. In: Journal of Pineal Research. 2015 ; Vol. 58, No. 2. pp. 234-250.
@article{ab2282625c484bf4a2f3be45a999b893,
title = "Melatonin uptake through glucose transporters: A new target for melatonin inhibition of cancer",
abstract = "Melatonin is present in a multitude of taxa and it has a broad range of biological functions, from synchronizing circadian rhythms to detoxifying free radicals. Some functions of melatonin are mediated by its membrane receptors but others are receptor-independent. For the latter, melatonin must enter into the cell. Melatonin is a derivative of the amino acid tryptophan and reportedly easily crosses biological membranes due to its amphipathic nature. However, the mechanism by which melatonin enters into cells remains unknown. Changes in redox state, endocytosis pathways, multidrug resistance, glycoproteins or a variety of strategies have no effect on melatonin uptake. Herein, it is demonstrated that members of the SLC2/GLUT family glucose transporters have a central role in melatonin uptake. When studied by docking simulation, it is found that melatonin interacts at the same location in GLUT1 where glucose does. Furthermore, glucose concentration and the presence of competitive ligands of GLUT1 affect the concentration of melatonin into cells. As a regulatory mechanism, melatonin reduces the uptake of glucose and modifies the expression of GLUT1 transporter in prostate cancer cells. More importantly, glucose supplementation promotes prostate cancer progression in TRAMP mice, while melatonin attenuated glucose-induced tumor progression and prolonged the lifespan of tumor-bearing mice. This is the first time that a facilitated transport of melatonin is suggested. In fact, the important role of glucose transporters and glucose metabolism in cell fate might explain some of the diverse functions described for melatonin.",
keywords = "cancer, glucose, glucose transporter, Melatonin, prostate, transgenic adenocarcinoma of the mouse prostate, transporter",
author = "David Hevia and Pedro Gonz{\'a}lez-Men{\'e}ndez and Isabel Quiros-Gonz{\'a}lez and Ana Miar and Aida Rodr{\'i}guez-Garc{\'i}a and Tan, {Dun Xian} and Reiter, {Russel J} and Mayo, {Juan C.} and Sainz, {Rosa M.}",
year = "2015",
doi = "10.1111/jpi.12210",
language = "English (US)",
volume = "58",
pages = "234--250",
journal = "Journal of Pineal Research",
issn = "0742-3098",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Melatonin uptake through glucose transporters

T2 - A new target for melatonin inhibition of cancer

AU - Hevia, David

AU - González-Menéndez, Pedro

AU - Quiros-González, Isabel

AU - Miar, Ana

AU - Rodríguez-García, Aida

AU - Tan, Dun Xian

AU - Reiter, Russel J

AU - Mayo, Juan C.

AU - Sainz, Rosa M.

PY - 2015

Y1 - 2015

N2 - Melatonin is present in a multitude of taxa and it has a broad range of biological functions, from synchronizing circadian rhythms to detoxifying free radicals. Some functions of melatonin are mediated by its membrane receptors but others are receptor-independent. For the latter, melatonin must enter into the cell. Melatonin is a derivative of the amino acid tryptophan and reportedly easily crosses biological membranes due to its amphipathic nature. However, the mechanism by which melatonin enters into cells remains unknown. Changes in redox state, endocytosis pathways, multidrug resistance, glycoproteins or a variety of strategies have no effect on melatonin uptake. Herein, it is demonstrated that members of the SLC2/GLUT family glucose transporters have a central role in melatonin uptake. When studied by docking simulation, it is found that melatonin interacts at the same location in GLUT1 where glucose does. Furthermore, glucose concentration and the presence of competitive ligands of GLUT1 affect the concentration of melatonin into cells. As a regulatory mechanism, melatonin reduces the uptake of glucose and modifies the expression of GLUT1 transporter in prostate cancer cells. More importantly, glucose supplementation promotes prostate cancer progression in TRAMP mice, while melatonin attenuated glucose-induced tumor progression and prolonged the lifespan of tumor-bearing mice. This is the first time that a facilitated transport of melatonin is suggested. In fact, the important role of glucose transporters and glucose metabolism in cell fate might explain some of the diverse functions described for melatonin.

AB - Melatonin is present in a multitude of taxa and it has a broad range of biological functions, from synchronizing circadian rhythms to detoxifying free radicals. Some functions of melatonin are mediated by its membrane receptors but others are receptor-independent. For the latter, melatonin must enter into the cell. Melatonin is a derivative of the amino acid tryptophan and reportedly easily crosses biological membranes due to its amphipathic nature. However, the mechanism by which melatonin enters into cells remains unknown. Changes in redox state, endocytosis pathways, multidrug resistance, glycoproteins or a variety of strategies have no effect on melatonin uptake. Herein, it is demonstrated that members of the SLC2/GLUT family glucose transporters have a central role in melatonin uptake. When studied by docking simulation, it is found that melatonin interacts at the same location in GLUT1 where glucose does. Furthermore, glucose concentration and the presence of competitive ligands of GLUT1 affect the concentration of melatonin into cells. As a regulatory mechanism, melatonin reduces the uptake of glucose and modifies the expression of GLUT1 transporter in prostate cancer cells. More importantly, glucose supplementation promotes prostate cancer progression in TRAMP mice, while melatonin attenuated glucose-induced tumor progression and prolonged the lifespan of tumor-bearing mice. This is the first time that a facilitated transport of melatonin is suggested. In fact, the important role of glucose transporters and glucose metabolism in cell fate might explain some of the diverse functions described for melatonin.

KW - cancer

KW - glucose

KW - glucose transporter

KW - Melatonin

KW - prostate

KW - transgenic adenocarcinoma of the mouse prostate

KW - transporter

UR - http://www.scopus.com/inward/record.url?scp=84922814928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922814928&partnerID=8YFLogxK

U2 - 10.1111/jpi.12210

DO - 10.1111/jpi.12210

M3 - Article

VL - 58

SP - 234

EP - 250

JO - Journal of Pineal Research

JF - Journal of Pineal Research

SN - 0742-3098

IS - 2

ER -